A carregar...
Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?
The development of personalised therapies has ushered in a new and exciting era of cancer treatment for a variety of solid malignancies. Yet pancreatic ductal adenocarcinoma (PDAC) has failed to benefit from this paradigm shift, remaining notoriously refractory to targeted therapies. Chemotherapy is...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5355171/ https://ncbi.nlm.nih.gov/pubmed/27845911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13309 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|